A prospective, multicentre study of immune checkpoint inhibitors to monitor cardiac function in advanced melanoma patients
Latest Information Update: 06 Jun 2019
At a glance
- Drugs Ipilimumab (Primary) ; Nivolumab (Primary) ; Pembrolizumab (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 06 Jun 2019 New trial record.
- 04 Jun 2019 Results published in conjunction with 55th Annual Meeting of the American Society of Clinical Oncology (2019).